|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 118, Issue 4 1343-1351, Copyright © 1993 by Company of Biologists
JOURNAL ARTICLES |
AM Muller and EA Dzierzak
Laboratory of Gene Structure and Expression, National Institute for Medical Research, London, UK.
While hematopoietic stem cells from adult and fetal stages of murine development are capable of long term reconstitution of all mature blood lineages in vivo, embryonic hematopoietic stem cell repopulation in vivo has proved difficult. It is thought that there are many fewer hematopoietic stem cells in the embryo than in the fetal/adult stages of mouse development and that these cells possess a different developmental potential. One source of such cells are embryonic stem (ES) cells which can differentiate into most mature blood lineages in vitro. We have therefore used transplantation of differentiated ES cells to assess the hematopoietic potential of embryonic hematopoietic cells in vivo. We demonstrate here that precursors obtained from in vitro cultures of normal ES cells can contribute only to restricted and limited hematopoiesis in a mouse without leading to tumour formation. Repopulation occurs for greater than 6.5 months at levels ranging from 0.1% to 6% in B and T cell lineages in peripheral blood. In contrast to in vitro colony data demonstrating the myeloid lineage developmental potential of ES cells, no donor-derived myeloid repopulation was observed in CFU-S assays and no macrophage and mast cells were found in long term repopulated recipients. Thus, the hematopoietic potential of ES cells in vivo is limited to low levels of repopulation and is restricted to the lymphoid lineage.
This article has been cited by other articles:
|
|
 |
|
  E. E. Bouhassira 34 + 43 = early human blood lineage Blood, September 15, 2006; 108(6): 1787 - 1788. [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Fleming and D. T. Scadden Embryonic stem cells make human T cells PNAS, August 15, 2006; 103(33): 12213 - 12214. [Full Text] [PDF]
|
|
|
|
|
|
A. L. Olsen, D. L. Stachura, and M. J. Weiss Designer blood: creating hematopoietic lineages from embryonic stem cells Blood, February 15, 2006; 107(4): 1265 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Keller Embryonic stem cell differentiation: emergence of a new era in biology and medicine Genes & Dev., May 15, 2005; 19(10): 1129 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Wobus and K. R. Boheler Embryonic Stem Cells: Prospects for Developmental Biology and Cell Therapy Physiol Rev, April 1, 2005; 85(2): 635 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Burt, L. Verda, D.-A. Kim, Y. Oyama, K. Luo, and C. Link Embryonic Stem Cells As an Alternate Marrow Donor Source: Engraftment without Graft-Versus-Host Disease J. Exp. Med., April 5, 2004; 199(7): 895 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. van Loo, P. Bouwman, K.-W. Ling, S. Middendorp, G. Suske, F. Grosveld, E. Dzierzak, S. Philipsen, and R. W. Hendriks Impaired hematopoiesis in mice lacking the transcription factor Sp3 Blood, August 1, 2003; 102(3): 858 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chadwick, L. Wang, L. Li, P. Menendez, B. Murdoch, A. Rouleau, and M. Bhatia Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells Blood, August 1, 2003; 102(3): 906 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Q. Daley, M. A. Goodell, and E. Y. Snyder Realistic Prospects for Stem Cell Therapeutics Hematology, January 1, 2003; 2003(1): 398 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pinto do O, K. Richter, and L. Carlsson Hematopoietic progenitor/stem cells immortalized by Lhx2 generate functional hematopoietic cells in vivo Blood, May 13, 2002; 99(11): 3939 - 3946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. R. Perlingeiro, M. Kyba, and G. Q. Daley Clonal analysis of differentiating embryonic stem cells reveals a hematopoietic progenitor with primitive erythroid and adult lymphoid-myeloid potential Development, November 15, 2001; 128(22): 4597 - 4604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nakayama, J. Lee, and L. Chiu Vascular endothelial growth factor synergistically enhances bone morphogenetic protein-4-dependent lymphohematopoietic cell generation from embryonic stem cells in vitro Blood, April 1, 2000; 95(7): 2275 - 2283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Cheng, N. Rodrigues, H. Shen, Y. Yang, D. Dombkowski, M. Sykes, and D. T. Scadden Hematopoietic Stem Cell Quiescence Maintained by p21cip1/waf1 Science, March 10, 2000; 287(5459): 1804 - 1808. [Abstract] [Full Text]
|
|
|
|
|
|
N. Nakayama, I. Fang, and G. Elliott Natural Killer and B-Lymphoid Potential in CD34+ Cells Derived From Embryonic Stem Cells Differentiated in the Presence of Vascular Endothelial Growth Factor Blood, April 1, 1998; 91(7): 2283 - 2295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Potocnik, H. Kohler, and K. Eichmann Hemato-lymphoid in vivo reconstitution potential of subpopulations derived from in vitro differentiated embryonic stem cells PNAS, September 16, 1997; 94(19): 10295 - 10300. [Abstract] [Full Text] [PDF]
|
|
